Literature DB >> 11458279

New data on the ultrastructure of the corpus amylaceum (polyglucosan body).

L Leel-Ossy1.   

Abstract

During the semiquantitative evaluation of the occurrence of the corpus amylaceum (CA) in a large quantity of autopsy and biopsy material (1,407 cases), electromicroscopical (EM) and scanning EM examinations were carried out on 8 autopsied cases where CA was demonstrated. The EM examinations appeared to underline the astrocytic origin of the CA formation, which is initiated in the astrocytic fiber system by glycogen and other carbohydrate polymers. The biophysics of the development of the CA is indicative of the same mechanisms as for (mainly intracellular) inclusion bodies. The large amount of CA that develops at the predilection sites is a consequence of metabolic damage, a large quantity of cerebrospinal fluid and recurring disturbances in the barrier functions. The abundant CA may cause secondary blood-brain barrier disturbances. This working hypothesis demands further investigations and the continuation of research by modern immunocytochemical and ultrastructural methods recommended.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458279     DOI: 10.1007/BF03032582

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  18 in total

1.  [Age changes in the central nervous system of domestic animals].

Authors:  H A KETZ
Journal:  Z Alternsforsch       Date:  1959-06

2.  THE SITE OF FORMATION AND ULTRASTRUCTURE OF AMYLOID.

Authors:  B GUEFT; J J GHIDONI
Journal:  Am J Pathol       Date:  1963-11       Impact factor: 4.307

3.  Glycogenosis with amylopectinoid deposits in a 13-year-old girl.

Authors:  T Tuñón; O Bengoechea; J Narbona
Journal:  Clin Neuropathol       Date:  1988 May-Jun       Impact factor: 1.368

4.  The origin and the pathological significance of the corpus amylaceum.

Authors:  L Leel-Ossy
Journal:  Acta Neuropathol Suppl       Date:  1981

5.  A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora's disease and normal ageing.

Authors:  Y Robitaille; S Carpenter; G Karpati; S D DiMauro
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

6.  Intraneuritic corpora amylacea. Demonstration in orbital cortex of elderly subjects by means of early postmortem brain sampling and electron microscopy.

Authors:  A P Anzil; H Herrlinger; K Blinzinger; D Kronski
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974

7.  [Corpora amylacea in the human brain (author's transl)].

Authors:  H P Schwalbe; G Quadbeck
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975

8.  Intraneuronal polyglucosan bodies and peculiar inclusions in the midbrain-tegmentum of the aged.

Authors:  K Ikeda; K Kosaka; A Hori
Journal:  Jpn J Psychiatry Neurol       Date:  1987-12

9.  Adult polyglucosan body disease (APBD).

Authors:  F Gray; R Gherardi; A Marshall; I Janota; J Poirier
Journal:  J Neuropathol Exp Neurol       Date:  1988-07       Impact factor: 3.685

10.  Pleomorphic intra-neuronal polyglucosan bodies mainly restricted to the pallidium. A case report.

Authors:  S Yagishita; Y Itoh; T Nakano; N Amano; S Yokoi; O Hasegawa; T Tanaka
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

View more
  7 in total

1.  Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.

Authors:  Elisabet Augé; Carme Pelegrí; Gemma Manich; Itsaso Cabezón; Joan J Guinovart; Jordi Duran; Jordi Vilaplana
Journal:  Glia       Date:  2018-08-26       Impact factor: 7.452

2.  Osteopontin mediates the formation of corpora amylacea-like structures from degenerating neurons in the CA1 region of the rat hippocampus after ischemia.

Authors:  Tae-Ryong Riew; Xuyan Jin; Ji-Won Hwang; Soojin Kim; Hong Lim Kim; Mun-Yong Lee
Journal:  Cell Tissue Res       Date:  2022-06-11       Impact factor: 4.051

3.  Clinical Neuropathology image 6-2014: Corpora amylacea replacing cornu ammonis (CACA).

Authors:  Gabor G Kovacs; Daniele Risser
Journal:  Clin Neuropathol       Date:  2014 Nov-Dec       Impact factor: 1.368

4.  Corpora amylacea in human hippocampal brain tissue are intracellular bodies that exhibit a homogeneous distribution of neo-epitopes.

Authors:  Elisabet Augé; Ingo Bechmann; Núria Llor; Jordi Vilaplana; Martin Krueger; Carme Pelegrí
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

5.  Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organelles.

Authors:  Paula P Navarro; Christel Genoud; Daniel Castaño-Díez; Alexandra Graff-Meyer; Amanda J Lewis; Yvonne de Gier; Matthias E Lauer; Markus Britschgi; Bernd Bohrmann; Stephan Frank; Jürgen Hench; Gabriel Schweighauser; Annemieke J M Rozemuller; Wilma D J van de Berg; Henning Stahlberg; Sarah H Shahmoradian
Journal:  Sci Rep       Date:  2018-12-21       Impact factor: 4.379

6.  Lipopolysaccharide, Identified Using an Antibody and by PAS Staining, Is Associated With Corpora amylacea and White Matter Injury in Alzheimer's Disease and Aging Brain.

Authors:  Xinhua Zhan; Marisa Hakoupian; Lee-Way Jin; Frank R Sharp
Journal:  Front Aging Neurosci       Date:  2021-11-24       Impact factor: 5.750

7.  Corpora Amylacea in Neurodegenerative Diseases: Cause or Effect?

Authors:  Troy T Rohn
Journal:  Int J Neurol Neurother       Date:  2015-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.